ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,767Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 1278

$617K Total Retail Price of All Prescriptions

Rank: 67 out of 1278

831 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
22% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arizona
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 831 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

17% of this provider’s 831 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

0% of this provider’s 9,839 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

18% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arizona
LOVASTATIN 799 692 1 13
LEVOTHYROXINE SODIUM 492 421 2 2
HYDROCODONE-ACETAMINOPHEN 481 411 S3 3 7
METOPROLOL SUCCINATE 466 390 4 23
AMLODIPINE BESYLATE 433 395 5 5
OMEPRAZOLE 427 357 6 6
LOSARTAN-HYDROCHLOROTHIAZIDE 372 312 7 75
LISINOPRIL 360 276 8 1
ATENOLOL 357 307 9 11
METFORMIN HCL 245 191 10 4
LISINOPRIL-HYDROCHLOROTHIAZIDE 231 195 11 30
LOSARTAN POTASSIUM 224 192 12 19
HYDROCHLOROTHIAZIDE 210 183 13 8
ENALAPRIL MALEATE 189 154 14 58
SERTRALINE HCL 189 159 14 28
ALLOPURINOL 178 148 16 36
SIMVASTATIN 162 151 17 3
ZOLPIDEM TARTRATE 157 121 18 16
GABAPENTIN 152 117 19 12
TERAZOSIN HCL 143 140 20 59
ATORVASTATIN CALCIUM 138 113 21 15
METOPROLOL TARTRATE 130 125 22 9
CIPROFLOXACIN HCL 122 107 23 53
FLUTICASONE PROPIONATE 120 99 24 24
TRIAMTERENE-HCTZ 118 113 25 43
POTASSIUM CHLORIDE 116 101 26 21
GLIPIZIDE-METFORMIN 115 93 27 272
INSULIN SYRINGE 112 92 28 50
CLOPIDOGREL 111 81 29 45
WARFARIN SODIUM 109 93 30 17
RANITIDINE HCL 108 93 31 20
FINASTERIDE 107 103 32 82
ADVAIR DISKUS 106 96 33 49
GLIPIZIDE 96 87 34 35
LIPITOR 91 77 35 95
PROAIR HFA 80 53 36 26
FUROSEMIDE 77 64 37 10
LACTULOSE 72 62 38 168
LANTUS 72 51 38 33
ZOSTAVAX 70 49 40 130
PLAVIX 69 53 41 64
OXYCODONE-ACETAMINOPHEN 66 49 S2 42 29
TRAZODONE HCL 65 50 43 38
CARVEDILOL 65 51 43 39
FLUOXETINE HCL 61 58 45 41
CITALOPRAM HBR 61 51 45 22
PANTOPRAZOLE SODIUM 61 44 45 34
VENTOLIN HFA 60 38 48 267
TRAMADOL HCL-ACETAMINOPHEN 58 58 49 221
PAROXETINE HCL 58 46 49 56
NOVOLIN 70-30 57 28 51 160
ACETAMINOPHEN-CODEINE 56 51 S3 52 98
OXYBUTYNIN CHLORIDE 56 48 52 80
TRAMADOL HCL 55 39 54 25
SPIRONOLACTONE 54 37 55 78
PRAVASTATIN SODIUM 52 43 56 14
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.